Browsing Faculty of Health Sciences (FHS) by Author "Malogo, R"
Now showing items 1-5 of 5
-
Challenges experienced by the clinical team during the conduct of HIV vaccine clinical trials in Kenya
Omosa-Manyonyi, G; Jaoko, WG; Wakasiaka, S; Bwayo, J; Ndinya-Achola, J; Schmidt, C; Bhatt, K; Ogutu, H; K’Owino, D; Dally, L; Malogo, R; Fast, P (University of NairobiSchool of Medicine, 2005) -
Challenges of use and compliance with effective contraceptives among female participants in preventive HIV vaccine trials The Kenyan experience.
Ogutu, H; Wakasiaka, S; Malogo, R; Ndambuki, R; Nyange, J; Omosa, G; Anzala, O; Bwayo, J; Fast, P; Schmidt, C; Verlinde, C; Smith, C; Ndinya-Achola, J; Jaoko, W (University of NairobiSchool of Medicine, 2007) -
Effectiveness of syndromic approach to STI management in a high risk cohort, Nairobi, Kenya
Smith, D; Hoang, T; Achola, N; Malogo, R; Farah, B; Mbithi, J; Anzala, O; Jaoko, W; Priddy, F; Wakasiaka, S (University of NairobiSchool of Medicine, 2009) -
Pre-screening And ‘banking’ Participants For Clinical Research – Experience From Kenya Aids Vaccine Initiative (kavi)
Omosa-Manyonyi, G; Ogutu, H; Malogo, R; Mutua, G; Nyasani, D; Sajabi, R; Mahira, R; Ouattara, G; Mutisya, E; Maina, A; Nyange, J; Wairimu, J; Muriuki, M; Lunani, L; Ndambuki, R (University of NairobiCollege of Health Sciences, 2013-06)Introduction: Participation in clinical research is a voluntary exercise whereby a participant makes an informed choice to join a study. Clinical trials are robust experiments that require efficiency. HIV vaccine clinical ... -
Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults (2009).
Omosa-Manyonyi, G; Jaoko, W; Anzala, O; Ogutu, H; Ndambuki, R; Wakasiaka, S; Malogo, R; Kayitenkore, K; Karita, E; Schmidt, C; Fast, P; Komaroff, W; Cooper, A; Boaz, M; Gilmour, J; Dally, L; Ho, M; Smith, C; Graham, B (University of NairobiSchool of Medicine, 2009)